Antibacterial agents active against Gram negative bacilli in phase I, II, or III clinical trials

DL Paterson - Expert Opinion on Investigational Drugs, 2024 - Taylor & Francis
Introduction Antimicrobial resistance is a major threat to modern healthcare, and it is often
regarded that the antibiotic pipeline is 'dry.'Areas covered Antimicrobial agents active …

At the Intersection of Critical Care and Infectious Diseases: The Year in Review

SR Sabo, A Venkatramanan, AF Shorr - Biomedicines, 2024 - mdpi.com
Severe infection represents a leading reason for admission to the intensive care unit (ICU)
while nosocomial infection can arise as a complication of care in the ICU. The mortality and …

Inhaled drug delivery: a randomized study in intubated patients with healthy lungs

J Dugernier, D Le Pennec, G Maerckx… - Annals of intensive …, 2023 - Springer
Background The administration technique for inhaled drug delivery during invasive
ventilation remains debated. This study aimed to compare in vivo and in vitro the deposition …

Long-term assessment of functional capacity, muscle function, lung function, and quality of life in survivors of ventilator-associated pneumonia

LM Dias, JA da Cruz, AJ Lopes - Heliyon, 2024 - cell.com
Background and objective The many patients who develop ventilator-associated pneumonia
(VAP) have generated numerous VAP survivors who are not followed up in the long term …

An in vitro study of the effects of respiratory circuit setup and parameters on aerosol delivery during mechanical ventilation

L Reilly, M Mac Giolla Eain, S Murphy… - Frontiers in …, 2024 - frontiersin.org
Introduction Aerosol therapy is often prescribed concurrently during invasive mechanical
ventilation (IMV). This study determines the effects of nebuliser position, circuit …

Pathogenesis and therapeutic opportunities of gut microbiome dysbiosis in critical illness

NA Cho, K Strayer, B Dobson, B McDonald - Gut Microbes, 2024 - Taylor & Francis
For many years, it has been hypothesized that pathological changes to the gut microbiome
in critical illness is a driver of infections, organ dysfunction, and other adverse outcomes in …

Precise Antibiotic Delivery to the Lung Infection Microenvironment Boosts the Treatment of Pneumonia with Decreased Gut Dysbiosis

L Fu, S Huo, P Lin, J Wang, J Zhao, Y You, X Nie… - Acta Biomaterialia, 2024 - Elsevier
Bacterial pneumonia is a common disease with significant health risks. However, the
overuse antibiotics in clinics face challenges such as inadequate targeting and limited drug …

Improving Outcomes in Nosocomial Pneumonia: Recent Evidence and More Challenges

IH Masri, B Busack, AF Shorr - Pathogens, 2024 - mdpi.com
Nosocomial pneumonia (NP) represents a leading nosocomial infection and results in
substantial morbidity and cost. Over the last several years, the evidence has evolved which …

Ventilator-Associated Pneumonia, Ventilator-Associated Events, and Nosocomial Respiratory Viral Infections on the Leeside of the Pandemic

M Klompas - Respiratory Care, 2024 - rc.rcjournal.com
The COVID-19 pandemic has had an unprecedented impact on population health and
hospital operations. Over 7 million patients have been hospitalized for COVID-19 thus far in …

[HTML][HTML] Understanding antimicrobial pharmacokinetics in critically ill patients to optimize antimicrobial therapy: A narrative review

C Roger - Journal of Intensive Medicine, 2024 - Elsevier
Effective treatment of sepsis not only demands prompt administration of appropriate
antimicrobials but also requires precise dosing to enhance the likelihood of patient survival …